Dr. Gyorgy Baffy is an Associate Professor of Medicine at Harvard Medical School, Adjunct Associate Professor of Medicine in Gastroenterology at Boston University, and Chief of Gastroenterology at the VA Boston Healthcare System. He is a graduate of the University Medical School of Debrecen in Hungary. In addition, he obtained his PhD from his studies on growth factor-mediated calcium signaling as an NIH Fogarty Fellow in the Department of Biochemistry and Biophysics at the University of Pennsylvania. He trained in gastroenterology at the University of Michigan and the Brigham and Women’s Hospital. His research interests focus on various aspects of nonalcoholic fatty liver disease such as outcomes prediction, biomarkers of lipotoxicity, metabolic reprogramming, cancer bioenergetics, and hepatocellular carcinoma. He has been involved in various clinical trials that pertain to colorectal cancer screening. He organized multiple workshops and symposia on his research topics at major US conferences. He published over 60 peer-reviewed papers and book chapters. He has participated in numerous scientific review panels and provides editorial work for several journals in gastroenterology and hepatology. In 2014, he received a Fulbright US Scholar award to teach for a semester about current issues of obesity and related disorders at the University of Debrecen. He is a Fellow of the American College of Physicians, American Gastroenterological Association, and the American Association for the Study of Liver Diseases. He is the recipient of the Madaus Prize from the Madaus Liver Foundation and the Hetényi Medal of the Hungarian Gastroenterological Association.
- VA Boston Healthcare System
- University of Debrecen, MD
- Hungarian Academy of Sciences, PhD
- Published on 10/12/2018
Baffy G. Potential mechanisms linking gut microbiota and portal hypertension. Liver Int. 2018 Oct 12. PMID: 30312513.
- Published on 3/21/2018
Andolfi C, Baffy G, Fisichella PM. Whose patient is it? The path to multidisciplinary management of achalasia. J Surg Res. 2018 Aug; 228:8-13. PMID: 29907234.
- Published on 1/22/2018
Baffy G. Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease. Dig Dis Sci. 2018 Mar; 63(3):563-576. PMID: 29368124.
- Published on 11/13/2017
Sarkar M, Baffy G. Perinatal programming of adolescent nonalcoholic fatty liver disease: A case for gender inequality? Hepatology. 2018 01; 67(1):7-9. PMID: 28771759.
- Published on 2/21/2017
Baffy G, Fisichella PM. Gastrointestinal Surgery and Endoscopy: Recent Trends in Competition and Collaboration. Clin Gastroenterol Hepatol. 2017 Jun; 15(6):799-803. PMID: 28235574.
- Published on 1/11/2017
Baffy G. Mitochondrial uncoupling in cancer cells: Liabilities and opportunities. Biochim Biophys Acta. 2017 08; 1858(8):655-664. PMID: 28088333.
- Published on 5/4/2016
Karagozian R, Bhardwaj G, Wakefield DB, Baffy G. Obesity paradox in advanced liver disease: obesity is associated with lower mortality in hospitalized patients with cirrhosis. Liver Int. 2016 Oct; 36(10):1450-6. PMID: 27037497.
- Published on 2/29/2016
Tarnoki AD, Tarnoki DL, Littvay L, Garami Z, Molnar AA, Berczi V, Karlinger K, Baffy G. Environmental Factors Responsible for Variability of Hepatic Vein Flow: A Doppler Assessment in Healthy Twins. Chin J Physiol. 2016 Feb 29; 59(1):33-8. PMID: 26875560.
- Published on 12/4/2015
Baffy G. MicroRNAs in Nonalcoholic Fatty Liver Disease. J Clin Med. 2015; 4(12):1977-88. PMID: 26690233.
- Published on 12/1/2015
Imler TD, Morea J, Kahi C, Cardwell J, Johnson CS, Xu H, Ahnen D, Antaki F, Ashley C, Baffy G, Cho I, Dominitz J, Hou J, Korsten M, Nagar A, Promrat K, Robertson D, Saini S, Shergill A, Smalley W, Imperiale TF. Corrigendum: Multi-Center Colonoscopy Quality Measurement Utilizing Natural Language Processing. Am J Gastroenterol. 2015 Dec; 110(12):1743. PMID: 26673514.
View 46 more publications: View full profile at BUMC